0001628280-24-001190.txt : 20240111
0001628280-24-001190.hdr.sgml : 20240111
20240111170609
ACCESSION NUMBER: 0001628280-24-001190
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240109
FILED AS OF DATE: 20240111
DATE AS OF CHANGE: 20240111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Odence-Ford Marion
CENTRAL INDEX KEY: 0001845002
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38543
FILM NUMBER: 24529892
MAIL ADDRESS:
STREET 1: 400 WATER STREET
STREET 2: SUITE 200
CITY: ROCHESTER
STATE: MI
ZIP: 48307
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OptimizeRx Corp
CENTRAL INDEX KEY: 0001448431
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
ORGANIZATION NAME: 07 Trade & Services
IRS NUMBER: 261265381
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 260 CHARLES STREET
STREET 2: SUITE 302
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 248-651-6558
MAIL ADDRESS:
STREET 1: 260 CHARLES STREET
STREET 2: SUITE 302
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
wk-form4_1705010757.xml
FORM 4
X0508
4
2024-01-09
0
0001448431
OptimizeRx Corp
OPRX
0001845002
Odence-Ford Marion
C/O OPTIMIZERX CORPORATION
260 CHARLES STREET, SUITE 302
WALTHAM
MA
02453
0
1
0
0
General Counsel and CCO
1
Common Stock
2024-01-09
4
S
0
4000
15.1877
D
11114
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.01 to $15.41. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
/s/ Marion K. Odence-Ford
2024-01-11